New clinical trial for never smokers: The Harmonic™ clinical trial
The Harmonic™ clinical trial is enrolling participants in a Phase 2 multi-center study to evaluate an investigational new drug called LP-300. This trial is for never smoker patients with relapsed advanced primary adenocarcinoma of the lung, which is a type of non-small cell lung cancer (NSCLC) including RET positive NSCLC patients.
For more information:
https://www.harmonictrial.com/
Find a clinical trial near you: https://www.harmonictrial.com/clinical-trial-locations
Learn more about The Happy Lungs Supported RET Cancer research here.
